Sept. 30-Oct. 2, 2020 | 10:00AM EDT | 2:00PM UTC*
*Program is in development and subject to change
The biochemical modifications made to RNA after transcription, called the epitranscriptome, play a critical role in life. The development of new technologies has transformed the field in recent years. Our understanding of the reason for and regulation of RNA editing and modifications, as well as their roles in human infection and disease is deepening and therapeutic applications are emerging. This virtual conference will bring together leading experts in RNA editing and modifications, technology development, and medicine to present and discuss cutting edge research. We anticipate that participants of this conference will benefit from learning the cutting edge of the rapidly advancing field and help move the field forward by creating collaboration opportunities.
Program is intended for scientific researchers and clinical audiences.
Join us for this landmark virtual event, brought to you by Keystone Symposia.
Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD
Scholarships: September 9, 2020
Abstract Submission: September 9, 2020
#VKSRNAediting21
Graduate students and postdoctoral fellows, as well as individuals from low- and middle- income countries (all career stages) working in science and medicine related fields, are eligible to apply for a FREE registration code.
Find out more about financial aid opportunities here!
Speaking at this eSymposia
Omar Abudayyeh
Massachusetts Institute of Technology, USA
Peter Beal
University of California, Davis, USA
Grace Chen
Yale University School of Medicine, USA
Jianjun Chen
Beckman Research Institute of City of Hope, USA
Eli Eisenberg
Tel Aviv University, Israel
Michaela Frye
Deutsches Krebsforschungszentrum, Germany
Chuan He
University of Chicago, USA
Stacy M. Horner
Duke University Medical Center, USA
Michael G. Kharas
Memorial Sloan Kettering Cancer Center, USA
Kamil R. Kranc
Barts Cancer Institute, Queen Mary University of London, UK
Jin Billy Li
Stanford University, USA
Kate Meyer
Duke University, USA
Yunsun Nam
University of Texas Southwestern Medical Center, USA
Kazuko Nishikura
Wistar Institute, USA
Eva Maria Novoa Pardo
Centre for Genomic Regulation, Spain
F. Nina Papavasiliou
Deutsches Krebsforschungszentrum, Germany
Alexey Ruzov
University of Nottingham, UK
Thorsten Stafforst
Universität Tübingen, Germany
Noam Stern-Ginossar
Weizmann Institute of Science, Israel
Carl Walkley
St Vincent's Institute, Australia
Blerta Xhemalce
University of Texas, Austin, USA
Yi-Tao Yu
University of Rochester Medical Center, USA
Funding for this conference was made possible (in part) by 1R13CA254455-01 from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.
